» Articles » PMID: 36682372

Asthma

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2023 Jan 22
PMID 36682372
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is one of the most common chronic non-communicable diseases worldwide and is characterised by variable airflow obstruction, causing dyspnoea and wheezing. Highly effective therapies are available; asthma morbidity and mortality have vastly improved in the past 15 years, and most patients can attain good asthma control. However, undertreatment is still common, and improving patient and health-care provider understanding of when and how to adjust treatment is crucial. Asthma management consists of a cycle of assessment of asthma control and risk factors and adjustment of medications accordingly. With the introduction of biological therapies, management of severe asthma has entered the precision medicine era-a shift that is driving clinical ambitions towards disease remission. Patients with severe asthma often have co-existing conditions contributing to their symptoms, mandating a multidimensional management approach. In this Seminar, we provide a clinically focused overview of asthma; epidemiology, pathophysiology, diagnosis, and management in children and adults.

Citing Articles

The asthma diagnosis jigsaw puzzle: an adaptable teaching concept to facilitate the diagnosis of asthma in adults and children presenting to primary care.

Ryan D, Kocks J, Williams S, Correia de Sousa J, Barne M, Bates M NPJ Prim Care Respir Med. 2025; 35(1):14.

PMID: 40089496 DOI: 10.1038/s41533-024-00410-w.


Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma.

Khan M, Alteneder M, Reiter W, Krausgruber T, Dobnikar L, Madern M Nat Commun. 2025; 16(1):2565.

PMID: 40089475 DOI: 10.1038/s41467-025-57590-3.


Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.

Adler A, Bergwik J, Padra M, Papareddy P, Schmidt T, Dahlgren M Respir Res. 2025; 26(1):101.

PMID: 40087604 DOI: 10.1186/s12931-025-03175-z.


The Late Asthmatic Reaction Is in Part Independent from the Early Asthmatic Reactions.

Zielen S, Alemdar O, Wimmers A, Gronau L, Duecker R, Hutter M Int J Mol Sci. 2025; 26(5).

PMID: 40076712 PMC: 11900439. DOI: 10.3390/ijms26052088.


Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms.

Ding Z, Deng Y, Luo H, Liu C, Yang M, Xue H Front Pharmacol. 2025; 16:1505672.

PMID: 40066338 PMC: 11891354. DOI: 10.3389/fphar.2025.1505672.